YÜCE, H. Et Al. 2022. Myrisetin, 18-Beta Glycirretinic Acid and Hespidin Investigation of Antiproliferative Effects On L929 Healthy Cells and MCF-7 Breast Cancer Cells. 8th International Hippocrates Congress on Medical and Health Sciences , (Turkey), 741-749.

YÜCE, H., ŞAHİN, Y., BAŞAK TÜRKMEN, N., ÜNÜVAR, S., & ÇİFTÇİ, O., (2022). Myrisetin, 18-Beta Glycirretinic Acid and Hespidin Investigation of Antiproliferative Effects On L929 Healthy Cells and MCF-7 Breast Cancer Cells . 8th International Hippocrates Congress on Medical and Health Sciences (pp.741-749). , Turkey

YÜCE, HANDE Et Al. "Myrisetin, 18-Beta Glycirretinic Acid and Hespidin Investigation of Antiproliferative Effects On L929 Healthy Cells and MCF-7 Breast Cancer Cells," 8th International Hippocrates Congress on Medical and Health Sciences, Turkey, 2022

YÜCE, HANDE Et Al. "Myrisetin, 18-Beta Glycirretinic Acid and Hespidin Investigation of Antiproliferative Effects On L929 Healthy Cells and MCF-7 Breast Cancer Cells." 8th International Hippocrates Congress on Medical and Health Sciences , Turkey, pp.741-749, 2022

YÜCE, H. Et Al. (2022) . "Myrisetin, 18-Beta Glycirretinic Acid and Hespidin Investigation of Antiproliferative Effects On L929 Healthy Cells and MCF-7 Breast Cancer Cells." 8th International Hippocrates Congress on Medical and Health Sciences , Turkey, pp.741-749.

@conferencepaper{conferencepaper, author={HANDE YÜCE Et Al. }, title={Myrisetin, 18-Beta Glycirretinic Acid and Hespidin Investigation of Antiproliferative Effects On L929 Healthy Cells and MCF-7 Breast Cancer Cells}, congress name={8th International Hippocrates Congress on Medical and Health Sciences}, city={}, country={Turkey}, year={2022}, pages={741-749} }